IP Library Granted Patent US 8,796,213
Granted Patent B2
US 8,796,213 · App. 12/672,463 · Granted Aug 5, 2014

Apoaequorin-containing compositions and methods of using same

Inventor: Mark Y. Underwood (Madison, WI)
Assignee: Qunicy Bioscience, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,796,213
App. No.
12/672,463
Granted
Aug 5, 2014
Kind
B2
Abstract

Compositions containing apoaequorin and methods for their use in treating symptoms and disorders related to calcium imbalances associated with, for example, sleep quality, energy quality, mood quality, memory quality or pain are provided by the present invention.

Claims (9)

1. A method for treating a symptom or disorder associated with calcium imbalance, comprising administering to a subject in need of such treatment an effective amount of apoaequorin, wherein said apoaequorin is not administered with its cofactor, coelenterazine.

2. The method according to claim 1 , wherein the symptom or disorder associated with calcium imbalance is sleep-related and administration of apoaequorin to said subject improves sleep quality in the subject.

3. The method according to claim 1 , wherein the symptom or disorder associated with calcium imbalance is energy-related and administration of apoaequorin to said subject improves energy quality in the subject.

4. The method according to claim 1 , wherein the symptom or disorder associated with calcium imbalance is mood-related and administration of apoaequorin to said subject improves mood quality in the subject.

5. The method according to claim 1 , wherein the symptom or disorder associated with calcium imbalance is pain-related and administration of apoaequorin to said subject alleviates pain in the subject.

6. The method according to claim 1 , wherein the symptom or disorder associated with calcium imbalance is memory-related and administration of apoaequorin to said subject improves memory, as indicated by improved scores on a standardized cognitive assessment.

7. The method according to claim 1 , wherein the symptom or disorder associated with calcium imbalance is related to neuronal excitability, muscle contraction, membrane permeability, cell division, hormone secretion, bone mineralization, or cell death following ischemia.

8. The method according to claim 1 , wherein apoaequorin is administered to said subject in the form of a nutraceutical composition.

9. The method according to claim 1 , wherein apoaequorin is administered to said subject in the form of a capsule for oral delivery.

Assignments (4)
SECURITY INTEREST Recorded Oct 18, 2024
From: QUINCY BIOSCIENCE, LLC
To: TRUIST BANK
Reel/Frame 068938/0846 →
RELEASE OF SECURITY INTEREST Recorded Feb 27, 2017
From: BTH BANK, NA
To: QUINCY BIOSCIENCE LLC
Reel/Frame 041382/0671 →
SECURITY INTEREST Recorded Aug 26, 2015
From: QUINCY BIOSCIENCE, LLC
To: BTH BANK, A DIVISION OF BANKTEXAS, NATIONAL ASSOCIAITON
Reel/Frame 036424/0454 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2010
From: UNDERWOOD, MARK Y.
To: QUINCY BIOSCIENCES, LLC
Reel/Frame 025372/0849 →
Continuity (2)
Provisional Application 61035443 · Mar 11, 2008
Related Publication 20110124562A1 · May 26, 2011